Literature DB >> 2069506

Resistance to ectromelia virus infection in mice. Analysis of H-2-linked gene effects.

H C O'Neill1.   

Abstract

The mechanism for resistance to ectromelia infection has been investigated in B6 and B10 congenic strains of mice which carry different alleles at the H-2 major histocompatibility locus. Greater susceptibility in some B10 congenic strains of mice has been associated with higher viral titres in the draining popliteal and inguinal lymph nodes as well as spleen at 3 days post infection. T cells which develop cytotoxic function following in vitro culture in the presence of T cell growth factors have also been detected in the popliteal lymph nodes of B6/B10 congenic strains of mice as early as 3 days post infection. Greater cytotoxicity has been detected in cultures of cells from resistant B6/B10 mice than from the susceptible B10 congenic strain B10.G, or other semi-resistant B10 congenic strains which differ at the H-2 locus. The early activation of T cells appears to be under H-2 gene control and activated T cells may play an "early" role in controlling viral replication within the lymphoid system.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2069506     DOI: 10.1007/BF01314035

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  17 in total

1.  A role for early cytotoxic T cells in resistance to ectromelia virus infection in mice.

Authors:  H C O'Neill; M Brenan
Journal:  J Gen Virol       Date:  1987-10       Impact factor: 3.891

2.  T-cell-mediated cytotoxicity against herpes simplex virus-infected target cells.

Authors:  K Pfizenmaier; A Starzinski-Powitz; M Röllinghoff; D Falks; H Wagner
Journal:  Nature       Date:  1977-02-17       Impact factor: 49.962

3.  Monoclonal antibodies specific for H-2K and H-2D antigens on cytotoxic T cells can inhibit their function.

Authors:  H C O'Neill
Journal:  Proc Natl Acad Sci U S A       Date:  1986-03       Impact factor: 11.205

4.  Evidence that NK cells and interferon are required for genetic resistance to lethal infection with ectromelia virus.

Authors:  R O Jacoby; P N Bhatt; D G Brownstein
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

5.  Cell-mediated cytotoxicity against ectromelia virus-infected target cells. II. Identification of effector cells and analysis of mechanisms.

Authors:  I Gardner; N A Bowern; R V Blanden
Journal:  Eur J Immunol       Date:  1974-02       Impact factor: 5.532

6.  Effect of sublethal whole-body irradiation on subsequent secondary cytolytic T cell responses in vitro.

Authors:  O Kanagawa; J A Louis; H D Engers; J C Cerottini
Journal:  J Immunol       Date:  1983-01       Impact factor: 5.422

7.  Mouse-pox; infectious ectromelia of mice; a review.

Authors:  F FENNER
Journal:  J Immunol       Date:  1949-12       Impact factor: 5.422

8.  H-2-linked control of resistance to ectromelia virus infection in B10 congenic mice.

Authors:  H C O'Neill; R V Blanden; T J O'Neill
Journal:  Immunogenetics       Date:  1983       Impact factor: 2.846

9.  Mechanisms of recovery from a generalized viral infection: mousepox. II. Passive transfer of recovery mechanisms with immune lymphoid cells.

Authors:  R V Blanden
Journal:  J Exp Med       Date:  1971-05-01       Impact factor: 14.307

10.  Mechanisms of recovery from a generalized viral infection: mousepox. 3. Regression infectious foci.

Authors:  R V Blanden
Journal:  J Exp Med       Date:  1971-05-01       Impact factor: 14.307

View more
  3 in total

Review 1.  Natural pathogens of laboratory mice, rats, and rabbits and their effects on research.

Authors:  D G Baker
Journal:  Clin Microbiol Rev       Date:  1998-04       Impact factor: 26.132

2.  Serial backcross analysis of genetic resistance to mousepox, using marker loci for Rmp-2 and Rmp-3.

Authors:  D G Brownstein; P N Bhatt; L Gras; T Budris
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

Review 3.  Poxvirus tropism.

Authors:  Grant McFadden
Journal:  Nat Rev Microbiol       Date:  2005-03       Impact factor: 60.633

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.